Pharmacokinetics, safety, and tolerability of a new patritumab formulation in patients with advanced, refractory solid tumors.

被引：4
作者：
Papadopoulos, Kyriakos P.
Moore, Kathleen N.
Lush, Richard
Desai, Madhuri
Mahmood, Syed
Beckman, Robert A.
Mendell-Harary, Jeanne
机构：
[1] START South Texas Accelerated Res Therapeut LLC, San Antonio, TX USA
[2] Peggy & Charles Stephenson Oklahoma Canc Ctr, Oklahoma City, OK USA
[3] H Lee Moffitt Canc Ctr & Res Inst Inc, Tampa, FL USA
[4] Daiichi Sankyo, Edison, NJ USA
[5] Georgetown Univ, Med Ctr, Washington, DC 20007 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e14026
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14026
引用
收藏
页数：1
相关论文
共 50 条
[41]   A phase I study of the safety and tolerability of VLX600, an Iron Chelator, in patients with refractory advanced solid tumors [J].
Kabir Mody ;
Aaron S. Mansfield ;
Lalitha Vemireddy ;
Peter Nygren ;
Joachim Gulbo ;
Mitesh Borad .
Investigational New Drugs, 2019, 37 :684-692
[42]   Safety and tolerability of AZD5363 in Japanese patients with advanced solid tumors [J].
Tamura, Kenji ;
Hashimoto, Jun ;
Tanabe, Yuko ;
Kodaira, Makoto ;
Yonemori, Kan ;
Seto, Takashi ;
Hirai, Fumihiko ;
Arita, Shuji ;
Toyokawa, Gouji ;
Chen, Lan ;
Yamamoto, Hiroshi ;
Kawata, Toshio ;
Lindemann, Justin ;
Esaki, Taito .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 77 (04) :787-795
[43]   Safety and tolerability of AZD5363 in Japanese patients with advanced solid tumors [J].
Kenji Tamura ;
Jun Hashimoto ;
Yuko Tanabe ;
Makoto Kodaira ;
Kan Yonemori ;
Takashi Seto ;
Fumihiko Hirai ;
Shuji Arita ;
Gouji Toyokawa ;
Lan Chen ;
Hiroshi Yamamoto ;
Toshio Kawata ;
Justin Lindemann ;
Taito Esaki .
Cancer Chemotherapy and Pharmacology, 2016, 77 :787-795
[44]   Phase I and pharmacokinetic (PK) study of a new liposome-encapsulated doxorubicin formulation in patients with refractory solid tumors. [J].
Muñoz, C ;
Muñoz, M ;
Balaña, C ;
Pontón, JL ;
Garcia, M ;
Llorens, MA ;
GImeno, M ;
Rosell, R ;
Germá, JR ;
Izquierdo, MA .
ANNALS OF ONCOLOGY, 2000, 11 :134-135
[45]   A phase 1, first-in-human, open-label study evaluating the safety, tolerability, pharmacokinetics, and efficacy of TT125-802 in patients with advanced solid tumors. [J].
Boni, Valentina ;
Garralda, Elena ;
Colombo, Ilaria ;
Homicsko, Krisztian ;
Brana, Irene ;
Gruber, Dorothea ;
Fluckiger-Mangual, Stefanie .
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[46]   Open-label, multicenter, phase I study to assess safety and tolerability of adavosertib plus durvalumab in patients with advanced solid tumors. [J].
Patel, Manish R. ;
Falchook, Gerald Steven ;
Wang, Judy Sing-Zan ;
Imedio, Esteban Rodrigo ;
Kumar, Sanjeev ;
Motlagh, Pejvack ;
Miah, Kowser ;
Mugundu, Ganesh M. ;
Jones, Suzanne Fields ;
Spigel, David R. ;
Hamilton, Erika Paige .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[47]   Safety, Efficacy, and Pharmacokinetics of Metatinib Tromethamine Tablet in Patients with Advanced Refractory Solid Tumors: A Phase I Clinical Trial [J].
Cheng, Ke ;
Li, Xiao-Yu ;
Zhou, Yu-Wen ;
Liao, Zheng-Yin ;
Qiu, Meng ;
Bi, Feng ;
Zheng, Li .
ONCOLOGIST, 2021, 26 (08) :649-+
[48]   Phase I trial to evaluate safety, pharmacokinetics, and efficacy of sorafenib combined with docetaxel in patients with advanced, refractory solid tumors [J].
Awada, A. ;
Hendlisz, A. ;
Whenham, N. ;
Gil, T. ;
Christensen, O. ;
Lathia, C. ;
Bartholomeus, S. ;
Delabaye, I. ;
De Valeriola, D. ;
Brendel, E. ;
Delaunoit, T. ;
Piccart, M. .
ANNALS OF ONCOLOGY, 2007, 18 :39-39
[49]   A Multicenter, Phase I, Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of Etirinotecan Pegol in Patients with Refractory Solid Tumors [J].
Jameson, Gayle S. ;
Hamm, John T. ;
Weiss, Glen J. ;
Alemany, Carlos ;
Anthony, Stephen ;
Basche, Michele ;
Ramanathan, Ramesh K. ;
Borad, Mitesh J. ;
Tibes, Raoul ;
Cohn, Allen ;
Hinshaw, Ioana ;
Jotte, Robert ;
Rosen, Lee S. ;
Hoch, Ute ;
Eldon, Michael A. ;
Medve, Robert ;
Schroeder, Katrina ;
White, Erica ;
Von Hoff, Daniel D. .
CLINICAL CANCER RESEARCH, 2013, 19 (01) :268-278
[50]   The Effect of Renal Impairment on the Pharmacokinetics and Safety of Talazoparib in Patients with Advanced Solid Tumors [J].
Durairaj, Chandrasekar ;
Chakrabarti, Jayeta ;
Ferrario, Cristiano ;
Hirte, Holger W. ;
Babu, Sunil ;
Piha-Paul, Sarina A. ;
Plotka, Anna ;
Hoffman, Justin ;
Shi, Haihong ;
Wang, Diane D. .
CLINICAL PHARMACOKINETICS, 2021, 60 (07) :921-930
12345